Outcome on quality of life in a Canadian national sample of patients with schizophrenia and related psychotic disorders.

Saved in:
Bibliographic Details
Title: Outcome on quality of life in a Canadian national sample of patients with schizophrenia and related psychotic disorders.
Authors: Malla, A., Williams, R., Kopala, L., Smith, G., Talling, D., Balshaw, R.
Source: Acta Psychiatrica Scandinavica. Supplementum. May2006 Supplement 430, Vol. 113, p22-28. 7p. 1 Chart.
Subjects: Quality of life, Schizophrenia, Drug efficacy, Age, Gender, Multivariate analysis
Geographic Terms: Canada
Abstract: Objective: To examine changes in subjective and objective dimensions of quality of life (QoL) in a large Canadian sample of patients with diagnosis of schizophrenia or schizoaffective disorder treated in academic and non-academic settings over a 2-year period. Method: Patients recruited in the study across the country were assessed for QoL and functioning using the Client and Provider versions of the Wisconsin Quality of Life Questionnaire (WQoL) and the Short Form-36 (SF-36) at baseline ( n = 448), 1 year ( n = 308–353) and 2 years (188–297). Data were analyzed to examine change across time using multivariate analyses controlling for potential influence of variables such as age, regional variation, gender, duration of illness, type of treatment taken and baseline measures of symptoms and QoL. Results: The weighted quality of life index (W-QoL-I) showed a significant change on both the client and the provider versions of the WQoL while the physical and mental composites of the SF-36 showed change only at 2 years. These changes were influenced significantly by baseline scores on W-QoL-I and in the case of provider version of the WQoL by baseline Brief Psychiatric Rating Scale (BPRS) scores. Regional variation or type of medication had no impact on improvement in QoL. Conclusion: Within a naturalistic sample of schizophrenia patients treated and followed in routine care the overall QoL showed an improvement over time but this improvement was not influenced by the type of medication prescribed. [ABSTRACT FROM AUTHOR]
Copyright of Acta Psychiatrica Scandinavica. Supplementum is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 20069275
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Outcome on quality of life in a Canadian national sample of patients with schizophrenia and related psychotic disorders.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Malla%2C+A%2E%22">Malla, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Williams%2C+R%2E%22">Williams, R.</searchLink><br /><searchLink fieldCode="AR" term="%22Kopala%2C+L%2E%22">Kopala, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Smith%2C+G%2E%22">Smith, G.</searchLink><br /><searchLink fieldCode="AR" term="%22Talling%2C+D%2E%22">Talling, D.</searchLink><br /><searchLink fieldCode="AR" term="%22Balshaw%2C+R%2E%22">Balshaw, R.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Acta+Psychiatrica+Scandinavica%2E+Supplementum%22">Acta Psychiatrica Scandinavica. Supplementum</searchLink>. May2006 Supplement 430, Vol. 113, p22-28. 7p. 1 Chart.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Quality+of+life%22">Quality of life</searchLink><br /><searchLink fieldCode="DE" term="%22Schizophrenia%22">Schizophrenia</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+efficacy%22">Drug efficacy</searchLink><br /><searchLink fieldCode="DE" term="%22Age%22">Age</searchLink><br /><searchLink fieldCode="DE" term="%22Gender%22">Gender</searchLink><br /><searchLink fieldCode="DE" term="%22Multivariate+analysis%22">Multivariate analysis</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Canada%22">Canada</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Objective: To examine changes in subjective and objective dimensions of quality of life (QoL) in a large Canadian sample of patients with diagnosis of schizophrenia or schizoaffective disorder treated in academic and non-academic settings over a 2-year period. Method: Patients recruited in the study across the country were assessed for QoL and functioning using the Client and Provider versions of the Wisconsin Quality of Life Questionnaire (WQoL) and the Short Form-36 (SF-36) at baseline ( n = 448), 1 year ( n = 308–353) and 2 years (188–297). Data were analyzed to examine change across time using multivariate analyses controlling for potential influence of variables such as age, regional variation, gender, duration of illness, type of treatment taken and baseline measures of symptoms and QoL. Results: The weighted quality of life index (W-QoL-I) showed a significant change on both the client and the provider versions of the WQoL while the physical and mental composites of the SF-36 showed change only at 2 years. These changes were influenced significantly by baseline scores on W-QoL-I and in the case of provider version of the WQoL by baseline Brief Psychiatric Rating Scale (BPRS) scores. Regional variation or type of medication had no impact on improvement in QoL. Conclusion: Within a naturalistic sample of schizophrenia patients treated and followed in routine care the overall QoL showed an improvement over time but this improvement was not influenced by the type of medication prescribed. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Acta Psychiatrica Scandinavica. Supplementum is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=20069275
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/j.1600-0447.2006.00758.x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 22
    Subjects:
      – SubjectFull: Quality of life
        Type: general
      – SubjectFull: Schizophrenia
        Type: general
      – SubjectFull: Drug efficacy
        Type: general
      – SubjectFull: Age
        Type: general
      – SubjectFull: Gender
        Type: general
      – SubjectFull: Multivariate analysis
        Type: general
      – SubjectFull: Canada
        Type: general
    Titles:
      – TitleFull: Outcome on quality of life in a Canadian national sample of patients with schizophrenia and related psychotic disorders.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Malla, A.
      – PersonEntity:
          Name:
            NameFull: Williams, R.
      – PersonEntity:
          Name:
            NameFull: Kopala, L.
      – PersonEntity:
          Name:
            NameFull: Smith, G.
      – PersonEntity:
          Name:
            NameFull: Talling, D.
      – PersonEntity:
          Name:
            NameFull: Balshaw, R.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 05
              Text: May2006 Supplement 430
              Type: published
              Y: 2006
          Identifiers:
            – Type: issn-print
              Value: 00651591
          Numbering:
            – Type: volume
              Value: 113
          Titles:
            – TitleFull: Acta Psychiatrica Scandinavica. Supplementum
              Type: main
ResultId 1